Global Green's Salmonella Vaccine Produces No Stress in Poultry and Strengthens Immune System

Global Green's Salmonella Vaccine Produces No Stress in Poultry and Strengthens Immune System

TALLAHASSEE, Fla.--(BUSINESS WIRE)-- Global Green, Inc. (OTCBB:GOGC) today announced that Salmogenics, the Company's patented Salmonella vaccine for poultry, produces no stress in poultry. The vaccine is injected in-ovo, before the chick is formed, resulting in no stress to a live bird. In field studies, Salmogenics has also been proven to strengthen the immune system in poultry, providing more resources to fight stressors such as extreme weather conditions, vaccination, beak trimming, insufficient housing space and many such disturbing conditions.

"Stress in poultry could result in immune suppression, poor weight gain, high feed conversion rate and depression in egg production - in short, reduction in the general well-being as well as performance," according to a February 2013 article on www.worldpoultry.net.

Dr. Mehran Ghazvini, Chairman and CEO, stated, "Stressors in poultry can often be multiple and disastrous. With Salmogenics, the quality of life for the chickens is improved, returns to the poultry grower are increased, and the quality of the protein source for the consumer is improved."

Salmogenics is in the final stage of testing and trials before the final U.S. Department of Agriculture/Food Safety and Inspection Service ("USDA") approval for its commercial application.

Global Green, Inc. is a green pharmaceutical company committed to identifying technology platforms and commercializing products that contain natural organisms that are not genetically modified, utilizing pharmaceutical standards. Salmogenics, the Company's flagship product, was developed by Nutritional Health Institute Laboratories, LLC, research affiliate and majority shareholder. For more information, visit www.globalgreeninc.org.

Forward-Looking Statement

This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties, which include among others, the inherent uncertainties associated with smaller reporting companies, including without limitation, other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.